All Stories

  1. Vital Needs of Dutch Homeless Service Users: Responsiveness of Local Services in the Light of Health Equity
  2. Positive affective recovery in daily life as a momentary mechanism across subclinical and clinical stages of mental disorder (Preprint)
  3. Positive affective recovery in daily life as a momentary mechanism across subclinical and clinical stages of mental disorder: Experience Sampling Study (Preprint)
  4. Factors That Influence the Use of Electronic Diaries in Health Care: Scoping Review
  5. Pre-training inter-rater reliability of clinical instruments in an international psychosis research project
  6. Health Patterns Reveal Interdependent Needs of Dutch Homeless Service Users
  7. Network dynamics of momentary affect states and future course of psychopathology in adolescents
  8. Dysregulated Lipid Metabolism Precedes Onset of Psychosis
  9. The Importance of Context: An ESM Study in Forensic Psychiatry
  10. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
  11. Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
  12. Ecological momentary assessment versus retrospective assessment for measuring change in health-related quality of life following cardiac intervention
  13. Attachment as a framework to facilitate empowerment for people with severe mental illness
  14. Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway
  15. Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
  16. Early warning signals in psychopathology: what do they tell?
  17. A replication study of JTC bias, genetic liability for psychosis and delusional ideation
  18. Comparing psychotic experiences in low-and-middle-income-countries and high-income-countries with a focus on measurement invariance
  19. Monitoring risk assessment on an acute psychiatric ward: Effects on aggression, seclusion and nurse behaviour
  20. Qualitative analysis of clinicians’ perspectives on the use of a computerized decision aid in the treatment of psychotic disorders
  21. Ukrainian mental health services and World Psychiatric Association Expert Committee recommendations
  22. Introducing the DizzyQuest: an app-based diary for vestibular disorders
  23. Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study
  24. Lower emotional complexity as a prospective predictor of psychopathology in adolescents from the general population.
  25. The DizzyQuest: to have or not to have… a vertigo attack?
  26. Association of preceding psychosis risk states and non‐psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS‐2 cohort
  27. Polygenic risk score for schizophrenia was not associated with glycemic level (HbA1c) in patients with non-affective psychosis: Genetic Risk and Outcome of Psychosis (GROUP) cohort study
  28. Factors That Influence the Use of Electronic Diaries in Health Care: Scoping Review (Preprint)
  29. Expressive deficits and amotivation as mediators of the associations between cognitive problems and functional outcomes: Results from two independent cohorts
  30. The impact of emotion awareness and regulation on psychotic symptoms during daily functioning
  31. Digital assessment of working memory and processing speed in everyday life: Feasibility, validation, and lessons-learned
  32. Polygenic liability for schizophrenia and childhood adversity influences daily‐life emotion dysregulation and psychosis proneness
  33. Measuring resilience prospectively as the speed of affect recovery in daily life: a complex systems perspective on mental health
  34. An ecological momentary intervention incorporating personalised feedback to improve symptoms and social functioning in schizophrenia spectrum disorders
  35. Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study (Preprint)
  36. Parsing Psychology: Statistical and Computational Methods using Physiological, Behavioral, Social, and Cognitive Data
  37. A time-series network approach to auditory verbal hallucinations: Examining dynamic interactions using experience sampling methodology
  38. Childhood trauma and coping in patients with psychotic disorders and obsessive-compulsive symptoms and in un-affected siblings
  39. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum
  40. Measuring within-day cognitive performance using the experience sampling method: A pilot study in a healthy population
  41. Implementing Experience Sampling Technology for Functional Analysis in Family Medicine – A Design Thinking Approach
  42. TwinssCan — Gene-Environment Interaction in Psychotic and Depressive Intermediate Phenotypes: Risk and Protective Factors in a General Population Twin Sample
  43. Recovery from daily-life stressors in early and chronic psychosis
  44. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?
  45. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene–environment interaction. The EUGEI study
  46. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study
  47. Identifying psychosis spectrum disorder from experience sampling data using machine learning approaches
  48. Evidence for interaction between genetic liability and childhood trauma in the development of psychotic symptoms
  49. Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling
  50. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
  51. Childhood adversities and psychotic symptoms: The potential mediating or moderating role of neurocognition and social cognition
  52. Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia Pathogenesis
  53. The resource group method in severe mental illness: study protocol for a randomized controlled trial and a qualitative multiple case study
  54. Corrigendum to “Long-term course of negative symptom subdomains and relationship with outcome in patients with a psychotic disorder” [Schizophr. Res. 193 (2018) 173–181]
  55. The evidence‐based group‐level symptom‐reduction model as the organizing principle for mental health care: time for change?
  56. Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study
  57. Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study
  58. Potential Applications of Digital Technology in Assessment, Treatment, and Self-help for Hallucinations
  59. Functional recovery of individuals with serious mental illnesses: Development and testing of a new short instrument for routine outcome monitoring.
  60. Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study
  61. Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings
  62. Treatment results for severe psychiatric illness: which method is best suited to denote the outcome of mental health care?
  63. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions
  64. The development and evaluation of a computerized decision aid for the treatment of psychotic disorders
  65. Reducing distress and improving social functioning in daily life in people with auditory verbal hallucinations: study protocol for the ‘Temstem’ randomised controlled trial
  66. Subjective quality of life in psychosis: Evidence for an association with real world functioning?
  67. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial
  68. Sensitivity to Peer Evaluation and Its Genetic and Environmental Determinants: Findings from a Population-Based Twin Study
  69. The role of cognitive functioning in the relationship between childhood trauma and a mixed phenotype of affective-anxious-psychotic symptoms in psychotic disorders
  70. An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility
  71. Economic evaluation of an experience sampling method intervention in depression compared with treatment as usual using data from a randomized controlled trial
  72. Predicting Psychosis Using the Experience Sampling Method with Mobile Apps
  73. Constructing a Reward-Related Quality of Life Statistic in Daily Life—a Proof of Concept Study Using Positive Affect
  74. Network Approach to Understanding Emotion Dynamics in Relation to Childhood Trauma and Genetic Liability to Psychopathology: Replication of a Prospective Experience Sampling Analysis
  75. Demonstrating the reliability of transdiagnostic mHealth Routine Outcome Monitoring in mental health services using experience sampling technology
  76. The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia
  77. Familial liability to psychosis is a risk factor for multimorbidity in people with psychotic disorders and their unaffected siblings
  78. Is sensitivity to daily stress predictive of onset or persistence of psychopathology?
  79. White noise speech illusion and psychosis expression: An experimental investigation of psychosis liability
  80. Does the Social Functioning Scale reflect real-life social functioning? An experience sampling study in patients with a non-affective psychotic disorder and healthy control individuals
  81. The experience sampling method as an mHealth tool to support self-monitoring, self-insight, and personalized health care in clinical practice
  82. Psychological and Biological Validation of a Novel Digital Social Peer Evaluation Experiment (digi-SPEE)
  83. Exploring the use of Routine Outcome Monitoring in the treatment of patients with a psychotic disorder
  84. Autonomic Regulation and Auditory Hallucinations in Individuals With Schizophrenia: An Experience Sampling Study
  85. Evidence That the Impact of Childhood Trauma on IQ Is Substantial in Controls, Moderate in Siblings, and Absent in Patients With Psychotic Disorder
  86. Assertive community treatment and associations with delinquency
  87. Recurrent TRIO Fusion in Nontranslocation–Related Sarcomas
  88. Use of the experience sampling method in the context of clinical trials: Table 1
  89. A user-developed, user run recovery programme for people with severe mental illness: A randomised control trial
  90. Critical Slowing Down as a Personalized Early Warning Signal for Depression
  91. Change in daily life behaviors and depression: Within-person and between-person associations.
  92. Effects of momentary self-monitoring on empowerment in a randomized controlled trial in patients with depression
  93. Routine outcome measurement in the Netherlands – A focus on benchmarking
  94. Psychotic disorder and educational achievement: a family-based analysis
  95. Experience Sampling-Based Personalized Feedback and Positive Affect: A Randomized Controlled Trial in Depressed Patients
  96. Childhood trauma and childhood urbanicity in relation to psychotic disorder
  97. Flexible ACT & Resource-group ACT: Different Working Procedures Which Can Supplement and Strengthen Each Other. A Response
  98. Associations between Stereotype Awareness, Childhood Trauma and Psychopathology: A Study in People with Psychosis, Their Siblings and Controls
  99. Flexibility Index Test-60
  100. Measuring Health-Related Quality of Life by Experiences: The Experience Sampling Method
  101. Testing an mHealth Momentary Assessment Routine Outcome Monitoring Application: A Focus on Restoration of Daily Life Positive Mood States
  102. Evidence That Environmental and Genetic Risks for Psychotic Disorder May Operate by Impacting on Connections Between Core Symptoms of Perceptual Alteration and Delusional Ideation
  103. Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations
  104. Evidence that childhood urban environment is associated with blunted stress reactivity across groups of patients with psychosis, relatives of patients and controls
  105. Criminal Victimisation in People with Severe Mental Illness: A Multi-Site Prevalence and Incidence Survey in the Netherlands
  106. Stereotype Awareness, Self-Esteem and Psychopathology in People with Psychosis
  107. A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial
  108. Depression, subthreshold depression and comorbid anxiety symptoms in older Europeans: Results from the EURODEP concerted action
  109. Evidence That a Psychopathology Interactome Has Diagnostic Value, Predicting Clinical Needs: An Experience Sampling Study
  110. The distribution of self-reported psychotic-like experiences in non-psychotic help-seeking mental health patients in the general population; a factor mixture analysis
  111. Novel directions for psychiatric diagnosis: from psychopathology to motor function to monitoring technology
  112. Psychiatry beyond labels: introducingcontextual precision diagnosisacross stages of psychopathology
  113. Assertive Community Treatment and Associations with Substance Abuse Problems
  114. Beyond DSM and ICD: introducing “precision diagnosis” for psychiatry using momentary assessment technology
  115. FKBP5 as a possible moderator of the psychosis-inducing effects of childhood trauma
  116. Development of the Davos Assessment of Cognitive Biases Scale (DACOBS)
  117. Altered Transfer of Momentary Mental States (ATOMS) as the Basic Unit of Psychosis Liability in Interaction with Environment and Emotions
  118. Symptomatic remission in psychosis and real-life functioning
  119. Temporal dynamics of visual and auditory hallucinations in psychosis
  120. Daily life moment-to-moment variation in coping in people with a diagnosis of schizophrenia: state within trait psychosis
  121. The use of a Cumulative Needs for Care Monitor for individual treatment v. care as usual for patients diagnosed with severe mental illness, a cost-effectiveness analysis from the health care perspective
  122. Consumer-Providers in Assertive Community Treatment Programs: Associations With Client Outcomes
  123. A time-lagged momentary assessment study on daily life physical activity and affect.
  124. Childhood Trauma and Psychosis: A Case-Control and Case-Sibling Comparison Across Different Levels of Genetic Liability, Psychopathology, and Type of Trauma
  125. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability?
  126. Emotional Experience in Negative Symptoms of Schizophrenia—No Evidence for a Generalized Hedonic Deficit
  127. Psychotic exacerbation and emotional dampening in the daily life of patients with schizophrenia switched to aripiprazole therapy: a collection of standardized case reports
  128. Momentary assessment technology as a tool to help patients with depression help themselves
  129. Function assertive community treatment (FACT) and psychiatric service use in patients diagnosed with severe mental illness
  130. Does monitoring need for care in patients diagnosed with severe mental illness impact on Psychiatric Service Use? Comparison of monitored patients with matched controls
  131. Assertive Community Treatment in the Netherlands: Outcome and Model Fidelity
  132. Neuroticism explained? From a non-informative vulnerability marker to informative person-context interactions in the realm of daily life
  133. Translating assessments of the film of daily life into person-tailored feedback interventions in depression
  134. Emotional Experience and Estimates of D2Receptor Occupancy in Psychotic Patients Treated With Haloperidol, Risperidone, or Olanzapine
  135. Cognitive deficits in nonaffective functional psychoses: A study in the Democratic Republic of Congo
  136. Experience sampling research in individuals with mental illness: reflections and guidance
  137. Social needs in daily life in adults with Pervasive Developmental Disorders
  138. Unveiling patterns of affective responses in daily life may improve outcome prediction in depression: A momentary assessment study
  139. Do depression and pain intensity interfere with physical activity in daily life in patients with Chronic Low Back Pain?
  140. Psychosis reactivity to cannabis use in daily life: an experience sampling study
  141. Systematic monitoring of needs for care and global outcomes in patients with severe mental illness
  142. A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial
  143. Meeting risk with resilience: high daily life reward experience preserves mental health
  144. Transition from stress sensitivity to a depressive state: longitudinal twin study
  145. Depression and parkinsonism in older Europeans: results from the EURODEP concerted action
  146. The cumulative needs for care monitor: a unique monitoring system in the south of the Netherlands
  147. Concurrent Measurement of "Real-World" Stress and Arousal in Individuals With Psychosis: Assessing the Feasibility and Validity of a Novel Methodology
  148. Capturing coping with symptoms in people with a diagnosis of schizophrenia: introducing the MACS-24
  149. Experience sampling research in psychopathology: opening the black box of daily life
  150. Are social phobia and paranoia related, and which comes first?
  151. COMT Val158Met moderation of cannabis-induced psychosis: a momentary assessment study of ‘switching on’ hallucinations in the flow of daily life
  152. Momentary assessment research in psychosis.
  153. A real-life observational study of the effectiveness of FACT in a Dutch mental health region
  154. Mechanisms of gene–environment interactions in depression: evidence that genes potentiate multiple sources of adversity
  155. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder
  156. Executive function does not predict coping with symptoms in stable patients with a diagnosis of schizophrenia
  157. Susceptibility to Depression Expressed as Alterations in Cortisol Day Curve: A Cross-Twin, Cross-Trait Study
  158. Subjective Experience of Cognitive Failures as Possible Risk Factor for Negative Symptoms of Psychosis in the General Population
  159. The psychology of psychiatric genetics: Evidence that positive emotions in females moderate genetic sensitivity to social stress associated with the BDNF Val⁶⁶Met polymorphism.
  160. The use of the Camberwell Assessment of Need in treatment: what unmet needs can be met?
  161. Genetic risk of depression and stress-induced negative affect in daily life
  162. The Catechol-O-Methyl Transferase Val158Met Polymorphism and Experience of Reward in the Flow of Daily Life
  163. The association between cognition and functional outcome in first-episode patients with schizophrenia: mystery resolved?
  164. The dynamics of symptomatic and non-symptomatic coping with psychotic symptoms in the flow of daily life
  165. Evidence that moment-to-moment variation in positive emotions buffer genetic risk for depression: a momentary assessment twin study
  166. The relationship between cognitive dysfunction and stress sensitivity in schizophrenia
  167. An observational, “real life” trial of the introduction of assertive community treatment in a geographically defined area using clinical rather than service use outcome criteria
  168. A momentary assessment study of the relationship between affective and adrenocortical stress responses in daily life
  169. Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: A 10-year follow-up study
  170. The Role of Gender Differences and Other Client Characteristics in the Prevalence of DSM-IV Affective Disorders Among a European Therapeutic Community Population
  171. Validation of Remission Criteria for Schizophrenia
  172. Computerized experience sampling method (ESMc): Assessing feasibility and validity among individuals with schizophrenia
  173. Genes Making One Feel Blue in the Flow of Daily Life: A Momentary Assessment Study of Gene-Stress Interaction
  174. Evidence for instrument and family-specific variation of subclinical psychosis dimensions in the general population.
  175. Diurnal mood variation in major depressive disorder.
  176. Hospital comorbidity bias and the concept of schizophrenia
  177. Physical health and depressive symptoms in older Europeans
  178. Subtle Fluctuations in Psychotic Phenomena as Functional States of Abnormal Dopamine Reactivity in Individuals at Risk
  179. Behavioural sensitization to daily life stress in psychosis
  180. Do different psychotic experiences differentially predict need for care in the general population?
  181. Electronic monitoring of salivary cortisol sampling compliance in daily life
  182. The schizophrenia envirome
  183. Early adolescent cannabis exposure and positive and negative dimensions of psychosis